IP Library Granted Patent US 10,729,416
Granted Patent B2
US 10,729,416 · App. 15/954,725 · Granted Aug 4, 2020

Vascular closure with shape memory characteristic

Inventors: Cleon Stanley (Bloomington, IN); Ram H. Paul, Jr. (Bloomington, IN)
Assignee: Cook Medical Technologies LLC
A61B17/0057A61B2017/00628
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,729,416
App. No.
15/954,725
Granted
Aug 4, 2020
Kind
B2
Abstract

Devices for closing an internal opening, e.g. a hole in a blood vessel, include a shape memory function. Particular substances have been found to provide advantages in use, and in particular forms of closure structures.

Claims (25)

1. A vascular closure device, comprising

an internal member for placement within a blood vessel in the blood flow therein,

wherein the internal member is of a material comprising between approximately 27 to 38 percent polycaprolactone and between approximately 62 and 73 percent L-lactide in block copolymer form, wherein the internal member has a first unfolded or open configuration and a second folded or closed configuration, the internal member adapted to hold the second configuration without external force applied to it at a temperature less than body temperature, and wherein the internal member is adapted to adjust toward the first configuration when heat is applied to the internal member in the second configuration sufficient to increase its temperature to about 37 degrees Celsius.

2. The device of claim 1 , wherein the material comprises between approximately 30 to 35 percent polycaprolactone and between approximately 65 to 70 percent L-lactide in block copolymer form.

3. The device of claim 1 , wherein the material consists essentially of approximately 30 to 35 percent polycaprolactone and between approximately 65 to 70 percent L-lactide in block copolymer form.

4. The device of claim 3 , wherein in the first unfolded or open configuration, the internal member is at least partially in the shape of a dome.

5. The device of claim 4 , wherein in the first unfolded or open configuration, the internal member has two opposing rim portions each forming part of a circle or ellipse, and two parallel side surfaces intersecting each of the rim portions.

6. The device of claim 1 , wherein the material comprises polycaprolactone and L-lactide in a ratio of between approximately 3:7 and 7:13.

7. The device of claim 1 , wherein the internal member includes a monolithic stem extending proximally.

8. The device of claim 7 , wherein the device is adapted to be placed via a placement apparatus having a lumen with an internal diameter, and wherein in the second configuration a dimension of the member measured in a direction perpendicular to the stem is less than the internal diameter of the lumen of the placement apparatus.

9. The device of claim 8 , wherein in the first configuration the dimension of the member is greater than the internal diameter of the lumen of the placement apparatus.

10. A vascular closure system, comprising:

a delivery tube having a longitudinal lumen with a first diameter;

a closure device including an internal member for anchoring the closure device from within a blood vessel, at least the internal member comprising a material comprising between approximately 27 to 38 percent polycaprolactone and between approximately 62 and 73 percent L-lactide in block copolymer form, wherein the internal member has a first unstressed expanded condition and a second compact condition,

in the first condition the internal member has a width dimension greater than the first diameter,

in the second condition the width dimension of the internal member is reduced so that the width dimension is smaller than the first diameter, the second condition being held by the internal member without external application of force,

and wherein when the internal member in the second condition is moved from within the tube into a blood vessel in which blood is flowing at body temperature, the internal member moves from the second condition toward the first condition without substantial absorption of fluid.

11. The system of claim 10 , wherein at least the internal member comprises a material comprising between approximately 30 to 35 percent polycaprolactone and between approximately 65 and 70 percent L-lactide in block copolymer form.

12. The system of claim 11 , wherein the internal member consists essentially of polycaprolactone and L-lactide.

13. The system of claim 11 , wherein the internal member consists of polycaprolactone and L-lactide.

14. The system of claim 10 , wherein at least the internal member consists essentially of approximately 30 percent polycaprolactone and approximately 70 percent L-lactide.

15. The system of claim 10 , wherein the internal member in the first condition is at least partially dome-shaped.

16. The system of claim 15 , wherein the internal member includes two rim portions that are substantially in the shape of at least part of an ellipse, and first and second side edges that are parallel to each other and on either side of a center point, the first and second side edges each intersecting the two rim portions.

17. The system of claim 10 , wherein at least the internal member comprises a material comprising polycaprolactone and L-lactide in a ratio between approximately 3:7 and 7:13.

18. The system of claim 17 , wherein the material is in block copolymer form.

Assignments (3)
SECURITY INTEREST Recorded Feb 28, 2024
From: COOK MEDICAL TECHNOLOGIES LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 066700/0277 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 13, 2018
From: COOK INCORPORATED
To: COOK MEDICAL TECHNOLOGIES LLC
Reel/Frame 046345/0469 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 11, 2018
From: STANLEY, CLEON; PAUL, RAM H., JR.
To: COOK INCORPORATED
Reel/Frame 046321/0009 →
Continuity (3)
Continuation 14056470 · Oct 17, 2013
Provisional Application 61716182 · Oct 19, 2012
Related Publication 20180228480A1 · Aug 16, 2018
Cited By (1)
US 12,383,246